Two years have passed, but the Tyro (ASX: TYR) saga might still be one of the most memorable incidents that headlined the digital payments industry. For those who can’t recall what happened, payment terminals issued by Tyro experienced a 2-week outage in the busy new year period of January 2021, resulting in both financial and
Read More
Aussies just haven’t got the time and energy to work around a planned meal kit, and that’s not ending well for meal kit delivery services like My Food Bag (ASX: MFB), with its earnings down nearly 40%. At the end of January 2023, deliveries were down 11.8% compared to last year. Revenue was down 8.0%,
Read More
Timing is an extraordinary thing. During Covid, when respiratory devices sold like hotcakes, companies were golden if they knew how to talk up their products. However, it could only last so long. Take Aussie respiratory products company CleanSpace (ASX: CSX), for instance. It launched an IPO at the peak of the pandemic, at an IPO
Read More
Even as the global real estate market grapples with rising inflation, US tailwinds are bolstering real estate agents ranking website RateMyAgent (ASX: RMY). The Company is partnering with US real estate listings website Realtor.com, thus gaining access to a user base of over 100 million. RateMyAgent has snowballed in the US, boasting over 235,000 agents
Read More
During Covid, Aussies loaded up on alcohol, with sales increasing over 30% in March 2020 as compared to March 2019 and growing further as the pandemic progressed. In the same period, global superstar Adele even released an affirmatory song—I Drink Wine, an anthem defining the state of plenty of us. Of course, who benefits from
Read More
In a shocking turn of events, the Therapeutic Goods Australia (TGA) —the medicine regulatory authority in the country—has rejected medtech company Hydrix’s (ASX: HYD) application to distribute its cardiovascular device, Guardian, in Australia. The TGA was dissatisfied with the device’s effectiveness. According to the regulatory body, the AngelMed Guardian device didn’t demonstrate that the benefits
Read More
